Purchase Order 75N93020P00518

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $11,585.00 on August 4, 2020, for fifty tests each of HU CD183 BV711 1C6/CXCR3, with completion by September 3, 2020. Performance occurs in San Jose, California. The purchase order is firm fixed price with no small business set-aside. The award carries a Coronavirus COVID-19 national interest action code.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $11,535.00 on July 29, 2020, for Human IL-4 (Clone MP4-25D2) BB700 antibody reagent, 1 milligram quantity. Performance location is San Jose, California. The order was completed on August 28, 2020. The award was designated under the Coronavirus COVID-19 National Interest Action Code.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded Becton, Dickinson And Company (BD), a manufacturer of medical devices and supplies, a firm fixed-price purchase order valued at $20,116.80 for high parameter custom conjugates. This award does not have a set-aside designation. The award has a completion date of August 15, 2024. BD is a prime contractor that has received numerous federal contract awards...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $13,237.18 on October 19, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion date is January 20, 2021. The source does not specify the equipment or supplies purchased under this order.</p>

This is a $10,787.50 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a component of the Department of Health and Human Services National Institutes of Health, to Becton, Dickinson And Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for the supply of BD antibodies and does not have a set-aside designation. BD is an experienced federal contractor, holding several...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $362,388.00 on February 2, 2015, with ultimate completion on March 31, 2020. No small business set-aside was used. The order is firm fixed price. Place of performance is Bethesda, Maryland. The awardee, operating as BD Biosciences, supplies flow cytometry systems, laboratory instrumentation, reagents, and associated consumables and technical support services to federal...

<p>The National Institute of Allergy and Infectious Diseases issued a $21,515 delivery order to Becton, Dickinson and Company (BD Biosciences) on March 28, 2018, for fluorescently conjugated monoclonal antibodies and flow cytometry consumables for the Vaccine Research Center.</p> <p>Place of performance is San Jose, California. The order is firm fixed price with an ultimate completion date of April 6, 2018. No set-aside was applied.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Becton, Dickinson And Company, operating through its BD Diagnostic Systems division, to provide 35 BD Antibodies. The award, which did not utilize a set-aside designation, has a potential value of $8,442.60 and a completion date of January 24, 2019. Becton, Dickinson And Company is a major medical technology manufacturer that...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $260,967.29 on June 15, 2020, for a BD FACSAria Fusion SO laser option upgrade in support of COVID-19 response efforts. Place of performance is San Jose, California. The order carries firm fixed pricing and was scheduled for completion by September 16, 2020. No small business set-aside was used.</p>

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $751,407 purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for FACSymphony S6 analysis systems. The contract is associated with NIH's efforts to support coronavirus COVID-19 research and will provide the analysis systems to support this work. Performance will occur in San Jose, California over a period of...